Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Sarah A. Hurvitz, MD, UCLA Jonsson Comprehensive Cancer Center
home
Articles
Future Directions for Treatment of TNBC
October 23rd 2020
Phase 3 ASCENT Trial in mTNBC: Managing Adverse Events
October 23rd 2020
Phase 3 ASCENT Trial in mTNBC
October 23rd 2020
Sequencing Therapies for mTNBC
October 23rd 2020
Standard of Care for BRCA+ mTNBC
October 23rd 2020
Testing for PD-L1 Expression in mTNBC
October 23rd 2020
KEYNOTE-355 Trial in mTNBC
October 23rd 2020
Standard of Care for Metastatic TNBC
October 23rd 2020
Current Trials for Treatment of Early Stage TNBC
October 23rd 2020
Emerging Data on Biomarkers in ES TNBC
October 23rd 2020
ICI-Based Therapy in TNBC: Immune-Related Adverse Events
October 23rd 2020
Role of Immune Checkpoint Inhibitor-Based Therapy in ES TNBC
October 23rd 2020
Early Stage TNBC: Phase 3 IMpassion031 Study
October 23rd 2020
Key Trials in ICI-Based Therapy for Early Stage TNBC
October 23rd 2020
Role of pCR in Early Stage TNBC Management
October 23rd 2020
Standard of Care for Early-Stage TNBC
October 23rd 2020